Debiopharm
  • Booth Overview
  • About us
  • Partnering with us
  • Product focus
  • Digital Health
  • Our latest news
  • Pipeline
Contact
Back

Digital Health

We invest in Smart Data & Digital Health (focusing on the oncology and infectious disease applications)

  • Smart Data

    By Smart Data we mean companies that leverage medical data and AI to have an impact on either the patient journey or the development of pharmaceutical products. We are interested for example in real world data, patient recruitment and adherence.

  • Digital health

    By Digital Health we mean tools and technologies that add medical value to patient care, such as digital patient monitoring, digital therapeutics, or clinical decision support systems. Consumer products and wellness are outside of our investment focus.

Debiopharm-StartupFunding-Criteria
Company stage
Late pilot or early commercial
Investment round
Series A and B
Our typical initial investment
$3M - 5M

Our recent investments

  • A DTx platform in oncology creating patient engagement and leading positive health outcomes

    More info
  • An end-to-end scientific solutions company developing novel digital endpoints from wearable sensor data

    More info
  • An AI-based platform for reducing the time and cost of drug development through in silico translational medicine

    More info

Our complete investment portfolio

Discover

Are you an entrepreneur looking for funding? What we bring as investors

  • Debiopharm-Board of Directors icon

    Active participation in the board of directors

  • Debiopharm-Pharma-Expertise

    Pharma & healthcare development, regulatory and market expertise

  • Debiopharm-Experience-Icon

    Experience in growing small companies

  • Debiopharm-Value-Creation

    Focus on long term value creation

Tanja Dowe CEO of Debiopharm Innovation Fund S.A.

  • About us

  • Partnering with us

  • Product focus

  • Digital Health

  • Our latest news

  • Pipeline